Despite delivering impressive second-quarter results, Abbott Laboratories (ABT) shares were trading 1.7% lower at the time of writing this article. The company also raised its FY2022 earnings guidance well above analyst expectations. ABT's Q2 Beat The company reported stellar quarterly earnings of $1.43 per share, which is significantly higher than analysts’ estimates of $1.14 per share and 22.2% higher than earnings reported in the prior-year period. Similarly, revenue climbed 10.6% year-over-year to $11.3 billion, compared to the prior-year period and outpaced the Street’s estimate of $10.3 billion. The outstanding revenue growth is attributed to higher organic sales growth of 14.3% as well as global COVID-19 testing-related sales of $2.
https://www.tipranks.com/news/abbott-posts-q2-beat-raises-eps-guidance?utm_source=advfn.com&utm_medium=referral
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
Von Aug 2022 bis Sep 2022 Click Here for more Abbott Laboratories Charts.
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
Von Sep 2021 bis Sep 2022 Click Here for more Abbott Laboratories Charts.